Amayu Health

Amayu Health operates a Germany-focused platform for ketamine therapy in mental health and related conditions. The company positions itself as an information and matching layer: it explains ketamine therapy to prospective patients and refers them to specialised independent partner physicians and partner therapists who deliver the actual care. The stated clinical scope covers depression, anxiety, trauma, obsessive-compulsive disorder, chronic pain, long COVID, burnout, migraine and addiction, with the target group described as people for whom prior treatments have not worked sufficiently or who experienced side effects from psychotropic medication.

The patient pathway is structured in four steps: a free online orientation consultation; an initial medical video consultation with a partner physician to build an individual treatment plan; in-person ketamine treatments at a medical practice with self-employed partner physicians present throughout the session; and online psychological preparation and integration sessions by video with partner therapists. Supporting features described include digital patient intake, online appointment booking, one-to-one on-site treatment, payment by invoice after treatment, and data protection. The company states that treatment can often begin within a few days and that partner physicians come from established clinics such as the Charité. Third-party ecosystem data describes the offering as medical ketamine therapy for depression, anxiety, trauma, obsessive-compulsive disorder, chronic pain and similar conditions, and lists no known external funding.